These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 30012566)

  • 21. Alternative microexon splicing by RBFOX2 and PTBP1 is associated with metastasis in colorectal cancer.
    Mochizuki Y; Funayama R; Shirota M; Kikukawa Y; Ohira M; Karasawa H; Kobayashi M; Ohnuma S; Unno M; Nakayama K
    Int J Cancer; 2021 Nov; 149(10):1787-1800. PubMed ID: 34346508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic Implication of Urothelial Stem Cell Markers Differs According to Primary Tumour Location in Non-Muscle-Invasive Bladder Cancer.
    Wang L; Zhao J; Yang C; Kuang R; Kazobinka G; Pang Z; Hou T
    Cell Physiol Biochem; 2018; 48(6):2364-2373. PubMed ID: 30114689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PTBP1 as a Promising Predictor of Poor Prognosis by Regulating Cell Proliferation, Immunosuppression, and Drug Sensitivity in SARC.
    Gong H; Jiang A; Jiang R; Wang Y; Zhang D; Wu Z; Xiao J
    Oxid Med Cell Longev; 2022; 2022():5687238. PubMed ID: 35651729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PTBP1 is a Novel Poor Prognostic Factor for Glioma.
    Liu P; He GC; Tan YZ; Liu GX; Liu AM; Zhu XP; Zhou Y; Hu WM
    Biomed Res Int; 2022; 2022():7590997. PubMed ID: 35299889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A pan-cancer analysis of the oncogenic role of polypyrimidine tract binding protein 1 (PTBP1) in human tumors.
    Huang Q; Gu S; Fang J; Li X; Lin L
    Medicine (Baltimore); 2022 Dec; 101(52):e32428. PubMed ID: 36595978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pan-cancer multi-omics analysis of PTBP1 reveals it as an inflammatory, progressive and prognostic marker in glioma.
    Ye Z; Zhong Y; Zhang Z
    Sci Rep; 2024 Jun; 14(1):14584. PubMed ID: 38918441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Large-scale remodeling of a repressed exon ribonucleoprotein to an exon definition complex active for splicing.
    Wongpalee SP; Vashisht A; Sharma S; Chui D; Wohlschlegel JA; Black DL
    Elife; 2016 Nov; 5():. PubMed ID: 27882870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PTBP1 acts as a dominant repressor of the aberrant tissue-specific splicing of ISCU in hereditary myopathy with lactic acidosis.
    Rawcliffe DFR; Österman L; Nordin A; Holmberg M
    Mol Genet Genomic Med; 2018 Nov; 6(6):887-897. PubMed ID: 30209894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PTBP1 modulates osteosarcoma chemoresistance to cisplatin by regulating the expression of the copper transporter SLC31A1.
    Cheng C; Ding Q; Zhang Z; Wang S; Zhong B; Huang X; Shao Z
    J Cell Mol Med; 2020 May; 24(9):5274-5289. PubMed ID: 32207235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long noncoding RNA MIR31HG and its splice variants regulate proliferation and migration: prognostic implications for muscle invasive bladder cancer.
    Wu S; Nitschke K; Worst TS; Fierek A; Weis CA; Eckstein M; Porubsky S; Kriegmair M; Erben P
    J Exp Clin Cancer Res; 2020 Dec; 39(1):288. PubMed ID: 33334367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of caldesmon is associated with tumor progression in patients with primary non-muscle-invasive bladder cancer.
    Lee MS; Lee J; Kim JH; Kim WT; Kim WJ; Ahn H; Park J
    Oncotarget; 2015 Nov; 6(37):40370-84. PubMed ID: 26430961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A developmentally regulated spliced variant of PTBP1 is upregulated in type 1 diabetic hearts.
    Belanger K; Nutter CA; Li J; Yu P; Kuyumcu-Martinez MN
    Biochem Biophys Res Commun; 2019 Feb; 509(2):384-389. PubMed ID: 30594394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unraveling UCA1 lncRNA prognostic utility in urothelial bladder cancer.
    Avgeris M; Tsilimantou A; Levis PK; Rampias T; Papadimitriou MA; Panoutsopoulou K; Stravodimos K; Scorilas A
    Carcinogenesis; 2019 Aug; 40(8):965-974. PubMed ID: 30815670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alternative splicing in bladder cancer: potential strategies for cancer diagnosis, prognosis, and treatment.
    Montero-Hidalgo AJ; Pérez-Gómez JM; Martínez-Fuentes AJ; Gómez-Gómez E; Gahete MD; Jiménez-Vacas JM; Luque RM
    Wiley Interdiscip Rev RNA; 2023; 14(3):e1760. PubMed ID: 36063028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-145 negatively regulates Warburg effect by silencing KLF4 and PTBP1 in bladder cancer cells.
    Minami K; Taniguchi K; Sugito N; Kuranaga Y; Inamoto T; Takahara K; Takai T; Yoshikawa Y; Kiyama S; Akao Y; Azuma H
    Oncotarget; 2017 May; 8(20):33064-33077. PubMed ID: 28380435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NOVA1 directs PTBP1 to hTERT pre-mRNA and promotes telomerase activity in cancer cells.
    Sayed ME; Yuan L; Robin JD; Tedone E; Batten K; Dahlson N; Wright WE; Shay JW; Ludlow AT
    Oncogene; 2019 Apr; 38(16):2937-2952. PubMed ID: 30568224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PTBP1 promotes the growth of breast cancer cells through the PTEN/Akt pathway and autophagy.
    Wang X; Li Y; Fan Y; Yu X; Mao X; Jin F
    J Cell Physiol; 2018 Nov; 233(11):8930-8939. PubMed ID: 29856478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RNA-binding proteins RBM20 and PTBP1 regulate the alternative splicing of FHOD3.
    Lorenzi P; Sangalli A; Fochi S; Dal Molin A; Malerba G; Zipeto D; Romanelli MG
    Int J Biochem Cell Biol; 2019 Jan; 106():74-83. PubMed ID: 30468920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer-Specific Energy Metabolism in Rhabdomyosarcoma Cells Is Regulated by MicroRNA.
    Sugito N; Taniguchi K; Kuranaga Y; Ohishi M; Soga T; Ito Y; Miyachi M; Kikuchi K; Hosoi H; Akao Y
    Nucleic Acid Ther; 2017 Dec; 27(6):365-377. PubMed ID: 28981396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary Cell-Free DNA IQGAP3/BMP4 Ratio as a Prognostic Marker for Non-Muscle-Invasive Bladder Cancer.
    Xu Y; Kim YH; Jeong P; Piao XM; Byun YJ; Seo SP; Kang HW; Kim WT; Lee JY; Ryu DH; Choi JW; Kim IY; Moon SK; Choi YH; Yun SJ; Kim WJ
    Clin Genitourin Cancer; 2019 Jun; 17(3):e704-e711. PubMed ID: 31088707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.